Augmentation of Interstitial Cystitis–Bladder Pain Syndrome Treatment With Meditation and Yoga DOI

Angela Dao,

Yuko M. Komesu, Sierra M. Jansen

et al.

Obstetrics and Gynecology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 2, 2025

OBJECTIVE: To investigate whether yoga and meditation added to usual care improves treatment response in women with interstitial cystitis–bladder pain syndrome. METHODS: This randomized trial compared syndrome receiving standard alone (control group) those plus (mind–body group). Standard was defined as behavioral changes or medications recommended by the American Urological Association. Individuals control group received care, mind–body augmented a commercially available application standardized tutorial video. Both groups continued their current treatments. The primary outcome modified GRA (Global Response Assessment), comparing responders (moderately, markedly improved) nonresponders at 12 weeks. On power analysis assuming α=5% β=80%, sample size of 82 participants required find 30% difference on between groups. Weekly scores over weeks were also compared. Secondary outcomes included ICPI (Interstitial Cystitis Problem Index)/ICSI Symptom Index), pain, interference, anxiety/depression, self-efficacy escalation RESULTS: Among 97 (49 group, 48 group), did not differ characteristics symptoms baseline. had more (31/43 [72.1%] vs 10/39 [25.6%], relative risk [RR] 2.8, 95% CI, 1.6–4.6), corroborated superior weekly results beneficial change (RR 1.8, 0.5–3.1), ICSI 1.9, 0.2–3.6), 1.4, 0.4–2.5) than less (2/45 [4.4%] 14/42 [33.3%], RR 0.13, 0.03–0.55). CONCLUSION: addition associated improved fewer additional interventions alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT04820855.

Language: Английский

2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats DOI Creative Commons
Samantha Taylor, Søren Boysen, Tony Buffington

et al.

Journal of Feline Medicine and Surgery, Journal Year: 2025, Volume and Issue: 27(2)

Published: Feb. 1, 2025

Practical relevance: Lower urinary tract signs (LUTS) such as dysuria, haematuria, periuria, pollakiuria and stranguria can occur the result of a variety underlying conditions diagnostic investigation is required to uncover cause select appropriate treatment. Aim: The '2025 iCatCare consensus guidelines on diagnosis management lower diseases in cats' provide an overview common presenting caused by feline (LUT) cats, which often are indistinguishable between different causes. Guidelines set out approach affected cats before focusing most causes LUTS: idiopathic cystitis (FIC), urolithiasis, infection urethral obstruction. aim practitioners with practical information these problematic conditions. Clinical challenges: fact that LUTS similar despite creates challenge. LUTS, FIC, challenging manage due complex pathogenesis involving organs outside LUT. Urethral obstruction life-threatening complication various LUT recurrent lead relinquishment or euthanasia cats. Evidence base: These have been created panel experts brought together International Cat Care (iCatCare) Veterinary Society (formerly Feline Medicine [ISFM]). Information based available literature, expert opinion members' experience.

Language: Английский

Citations

1
Augmentation of Interstitial Cystitis–Bladder Pain Syndrome Treatment With Meditation and Yoga DOI

Angela Dao,

Yuko M. Komesu, Sierra M. Jansen

et al.

Obstetrics and Gynecology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 2, 2025

OBJECTIVE: To investigate whether yoga and meditation added to usual care improves treatment response in women with interstitial cystitis–bladder pain syndrome. METHODS: This randomized trial compared syndrome receiving standard alone (control group) those plus (mind–body group). Standard was defined as behavioral changes or medications recommended by the American Urological Association. Individuals control group received care, mind–body augmented a commercially available application standardized tutorial video. Both groups continued their current treatments. The primary outcome modified GRA (Global Response Assessment), comparing responders (moderately, markedly improved) nonresponders at 12 weeks. On power analysis assuming α=5% β=80%, sample size of 82 participants required find 30% difference on between groups. Weekly scores over weeks were also compared. Secondary outcomes included ICPI (Interstitial Cystitis Problem Index)/ICSI Symptom Index), pain, interference, anxiety/depression, self-efficacy escalation RESULTS: Among 97 (49 group, 48 group), did not differ characteristics symptoms baseline. had more (31/43 [72.1%] vs 10/39 [25.6%], relative risk [RR] 2.8, 95% CI, 1.6–4.6), corroborated superior weekly results beneficial change (RR 1.8, 0.5–3.1), ICSI 1.9, 0.2–3.6), 1.4, 0.4–2.5) than less (2/45 [4.4%] 14/42 [33.3%], RR 0.13, 0.03–0.55). CONCLUSION: addition associated improved fewer additional interventions alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT04820855.

Language: Английский

Citations

0